Cagent Vascular initiates patient enrolment in Serranator vs. plain balloon angioplasty OCT study - Interventional News

Cagent Vascular initiates patient enrolment in Serranator vs. plain balloon angioplasty OCT study - Interventional News

Serranator Cagent Vascular has announced its first patient enrolment of the Serranator versus plain balloon angioplasty optical coherence tomography (OCT) study. This prospective, randomised (2:1 treatment to control) dual-centre study will enrol up to 60 patients. The study will utilise intravascular OCT imaging to demonstrate the mechanism of action (MOA) of the Serranator and compare the serration MOA to conventional angioplasty across a wide…

Cagent Begins Serranator OCT Study of Serration Angioplasty Versus POBA in BTK Arteries - Endovascular Today

April 10, 2025—Cagent Vascular, Inc. announced that the first patient was enrolled in the Serranator OCT study. The study will use intravascular optical coherence tomography (OCT) imaging to demonstrate the mechanism of action (MOA) of the company’s Serranator percutaneous transluminal angioplasty (PTA) serration balloon technology and compare it to plain old balloon angioplasty (POBA) across a range of lesion morphologies in below-the-knee arte…